Company
VarmX
Restoring blood coagulation in patients taking Factor Xa Direct Oral Anticoagulants (FXa-DOACs)
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Leiden, The Netherlands
- Founded
- 2016
- varmx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Our focus lies in the development of a breakthrough, swift-acting, and convenient universal bypassing agent that restores blood coagulation in patients taking Factor Xa Direct Oral Anticoagulants (FXa-DOACs).
Products
- Other
- VMX-C001
Loading relationship preview